PWM: Foods and Nutrients (2006)
Koivisto U, Fellenius J, Sjoden. Relations between parental mealtime practices and children’s food intake. Appetite 1994; 22: 245-258.PubMed ID: 7979342
To relate food intake of children aged 3-7 years to selected parental and child mealtime behaviors.
Family mealtimes were video taped 3 times, after the first video recording session the child’s weight and height were measured.
Dependent: Child’s adiposity: divided into two groups overweight & normal weight (weight-length index).
- Child eating behaviour and parental behaviour occurring at mealtime (video version of BATMAN – Bob’s and Tom’s method for assessing nutrition)
- Secondary Analysis (only 39 families participating in this analysis): Energy consumption and the intake of 10 nutrients including protein (g), Carbohydrates (g), Fat (g), Sucrose (g) (7-day dietary recording period).
Variables controlled for: Gender, age.
Statistical Analysis: Correlations & univariate analysis (using t-tests to test for significance).
Initial N: 50 children (25 males & 25 females)
Age: 3-7 years
Other relevant demographics: Swedish
Parental Influences: Parental control over child’s intake & Parental encouragement.
- We found no linear relationships between parental mealtime practices and child overweight.
* This could either be due to the fact that the overweight children participating in the study were only moderately overweight or to the cultural differences between the US and Sweden.
- Normal-weight children received more parental neutral statements about food than the overweight children.
Total Energy & Dietary Fat: % total calories
- There was no significant difference in either energy or nutrient intake between the normal weight (n=24) and the overweight (n=15), even though the overweight children had higher energy and nutrient intakes when expressed in absolute figures.
- No relationship between energy intake and overweight was found.
- Overweight (n=15) consumed more protein (g) than normal weight subjects (n=24); however the difference was not statistically significant (59 vs. 53 g).
- Overweight consumed more carbohydrate (g) than normal weight subjects; however the difference was not statistically significant (220 vs. 215 g).
- Overweight consumed more fat (g) than normal weight subjects; however the difference was not statistically significant (68 vs. 60 g).
- Overweight consumed more sucrose (g) than normal weight subjects; however the difference was not statistically significant (53 vs 51 g).
Parents of young children should be encouraged to use more positive or neutral verbal behaviors during meals.
|Government:||The Swedish Council for Forestry and Agricultural Research|
|University/Hospital:||University of Uppsala (Sweden)|
- Mean interrater reliability was 80% for child behaviors and 63% for parental behaviors – low interrater reliability for the parental behaviors.
- Small sample size & children in the study who were overweight were only mildly overweight.
- Study took place in university town, with a large number of inhabitants with academic degrees. Not representative for the Swedish preschool population.
- Only 106 of the 599 families initially participating in the questionnaire study were interested in further participation suggests that only families with greater interest in child food issues have participated in the present study.
Quality Criteria Checklist: Primary Research
|1.||Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies)||Yes|
|2.||Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about?||Yes|
|3.||Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice?||Yes|
|4.||Is the intervention or procedure feasible? (NA for some epidemiological studies)||Yes|
|1.||Was the research question clearly stated?||Yes|
|1.1.||Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified?||Yes|
|1.2.||Was (were) the outcome(s) [dependent variable(s)] clearly indicated?||Yes|
|1.3.||Were the target population and setting specified?||Yes|
|2.||Was the selection of study subjects/patients free from bias?||No|
|2.1.||Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study?||No|
|2.2.||Were criteria applied equally to all study groups?||Yes|
|2.3.||Were health, demographics, and other characteristics of subjects described?||No|
|2.4.||Were the subjects/patients a representative sample of the relevant population?||No|
|3.||Were study groups comparable?||???|
|3.1.||Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT)||No|
|3.2.||Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline?||???|
|3.3.||Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.)||Yes|
|3.4.||If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis?||???|
|3.5.||If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.)||???|
|3.6.||If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")?||N/A|
|4.||Was method of handling withdrawals described?||???|
|4.1.||Were follow-up methods described and the same for all groups?||No|
|4.2.||Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.)||No|
|4.3.||Were all enrolled subjects/patients (in the original sample) accounted for?||Yes|
|4.4.||Were reasons for withdrawals similar across groups?||???|
|4.5.||If diagnostic test, was decision to perform reference test not dependent on results of test under study?||N/A|
|5.||Was blinding used to prevent introduction of bias?||???|
|5.1.||In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate?||???|
|5.2.||Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.)||???|
|5.3.||In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded?||???|
|5.4.||In case control study, was case definition explicit and case ascertainment not influenced by exposure status?||N/A|
|5.5.||In diagnostic study, were test results blinded to patient history and other test results?||N/A|
|6.||Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described?||N/A|
|6.1.||In RCT or other intervention trial, were protocols described for all regimens studied?||N/A|
|6.2.||In observational study, were interventions, study settings, and clinicians/provider described?||Yes|
|6.3.||Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect?||No|
|6.4.||Was the amount of exposure and, if relevant, subject/patient compliance measured?||N/A|
|6.5.||Were co-interventions (e.g., ancillary treatments, other therapies) described?||N/A|
|6.6.||Were extra or unplanned treatments described?||N/A|
|6.7.||Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups?||N/A|
|6.8.||In diagnostic study, were details of test administration and replication sufficient?||N/A|
|7.||Were outcomes clearly defined and the measurements valid and reliable?||???|
|7.1.||Were primary and secondary endpoints described and relevant to the question?||Yes|
|7.2.||Were nutrition measures appropriate to question and outcomes of concern?||Yes|
|7.3.||Was the period of follow-up long enough for important outcome(s) to occur?||Yes|
|7.4.||Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures?||???|
|7.5.||Was the measurement of effect at an appropriate level of precision?||???|
|7.6.||Were other factors accounted for (measured) that could affect outcomes?||No|
|7.7.||Were the measurements conducted consistently across groups?||Yes|
|8.||Was the statistical analysis appropriate for the study design and type of outcome indicators?||???|
|8.1.||Were statistical analyses adequately described and the results reported appropriately?||Yes|
|8.2.||Were correct statistical tests used and assumptions of test not violated?||Yes|
|8.3.||Were statistics reported with levels of significance and/or confidence intervals?||Yes|
|8.4.||Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)?||N/A|
|8.5.||Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)?||Yes|
|8.6.||Was clinical significance as well as statistical significance reported?||N/A|
|8.7.||If negative findings, was a power calculation reported to address type 2 error?||No|
|9.||Are conclusions supported by results with biases and limitations taken into consideration?||Yes|
|9.1.||Is there a discussion of findings?||Yes|
|9.2.||Are biases and study limitations identified and discussed?||Yes|
|10.||Is bias due to study's funding or sponsorship unlikely?||Yes|
|10.1.||Were sources of funding and investigators' affiliations described?||Yes|
|10.2.||Was the study free from apparent conflict of interest?||Yes|